Summit Therapeutics, Inc. (SMMT)
15.36
+0.24
(+1.55%)
USD |
NASDAQ |
Oct 15, 16:00
15.46
+0.10
(+0.62%)
After-Hours: 20:00
Summit Therapeutics Market Cap : 12.19B for Oct. 15, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 14, 2026 | 12.00B |
| October 13, 2026 | 12.31B |
| October 12, 2026 | 13.59B |
| October 09, 2026 | 13.95B |
| October 08, 2026 | 13.62B |
| October 07, 2026 | 14.24B |
| October 06, 2026 | 13.73B |
| October 05, 2026 | 13.70B |
| October 02, 2026 | 13.29B |
| October 01, 2026 | 13.24B |
| September 30, 2026 | 13.41B |
| September 29, 2026 | 13.00B |
| September 28, 2026 | 12.28B |
| September 25, 2026 | 12.38B |
| September 24, 2026 | 12.99B |
| September 23, 2026 | 13.05B |
| September 22, 2026 | 13.58B |
| September 21, 2026 | 13.40B |
| September 18, 2026 | 14.16B |
| September 17, 2026 | 14.05B |
| September 16, 2026 | 13.72B |
| September 15, 2026 | 13.80B |
| September 14, 2026 | 14.61B |
| September 11, 2026 | 13.92B |
| September 10, 2026 | 13.48B |
| Date | Value |
|---|---|
| September 09, 2026 | 13.91B |
| September 08, 2026 | 13.71B |
| September 04, 2026 | 13.96B |
| September 03, 2026 | 13.59B |
| September 02, 2026 | 11.58B |
| September 01, 2026 | 11.23B |
| August 31, 2026 | 10.80B |
| August 28, 2026 | 10.89B |
| August 27, 2026 | 11.37B |
| August 26, 2026 | 11.29B |
| August 25, 2026 | 10.60B |
| August 24, 2026 | 10.10B |
| August 21, 2026 | 10.44B |
| August 20, 2026 | 9.858B |
| August 19, 2026 | 10.40B |
| August 18, 2026 | 10.17B |
| August 17, 2026 | 10.14B |
| August 14, 2026 | 10.59B |
| August 13, 2026 | 11.10B |
| August 12, 2026 | 11.98B |
| August 11, 2026 | 11.99B |
| August 10, 2026 | 11.79B |
| August 07, 2026 | 11.07B |
| August 06, 2026 | 10.74B |
| August 05, 2026 | 10.73B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovelStem International Corp. | 0.4687M |
| Brainstorm Cell Therapeutics, Inc. | 9.214M |
| Kezar Life Sciences, Inc. | 53.76M |
| Protara Therapeutics, Inc. | 141.51M |
| Clene, Inc. | 41.02M |
Market Cap Related Metrics
| PEG Ratio | -1.236 |
| Price to Book Value | 19.34 |
| Price | 15.36 |
| Earnings Yield | -7.28% |
| PEGY Ratio | -1.236 |